Personal profile
Biography
Professor Peter Fuller is currently Head of the Centre for Endocrinology and Metabolism at the Hudson Institute (formerly Prince Henry’s Institute of Medical Research) and Head of the Endocrinology Unit at Monash Health. He is a physician-scientist whose clinical and research training was in Melbourne followed by postdoctoral training at the Massachusetts General Hospital. His research interests lie primarily in understanding the molecular mechanisms of adrenocortical steroid hormone action. His group also studies the molecular pathogenesis of endocrine tumours. He has served on principle committees/boards of the Endocrine Society (USA), NHMRC, Cancer Council of Victoria, Victorian Cancer Agency, Cabrini Institute and Endocrine Society of Australia. He has received awards from the Welcome Trust, the Royal Australasian College of Physicians and the British Endocrine Society and the Endocrine Society of Australia. In 2015 he was made a Member (AM) in the General Division of the Order of Australia.
http://hudson.org.au/researcher-profile/peter-fuller/
External positions
Director, Endocrinology Unit, Monash Health
Research area keywords
- Endocrinology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
-
Advancing Ovarian Granulosa Cell Tumor Treatment: Structural Insights and Drug Discovery for the FOXL2C134W Mutation
Chu, S. (Primary Chief Investigator (PCI)), Wong, W. (Chief Investigator (CI)), Fuller, P. (Chief Investigator (CI)), Jobling, T. (Associate Investigator (AI)), Rosenbluh, S. (Associate Investigator (AI)) & Silke, J. (Associate Investigator (AI))
1/07/25 → 30/06/28
Project: Research
-
EQUIPping Tertiary Care for the Optimal Diagnosis of Primary Aldosteronism
Yang, J. (Primary Chief Investigator (PCI)), Fuller, P. (Chief Investigator (CI)), Stowasse, M. (Chief Investigator (CI)), Glendenning, P. (Chief Investigator (CI)), Lu, Z. X. (Chief Investigator (CI)), Chong, W. (Chief Investigator (CI)), Horvath, A. R. (Chief Investigator (CI)), Endre, Z. (Chief Investigator (CI)), Thuzar, M. (Chief Investigator (CI)), Shen, J. (Chief Investigator (CI)), Jong, I. (Chief Investigator (CI)), Leenaerts, M. (Associate Investigator (AI)), Gwini, S. (Associate Investigator (AI)), Chen, G. (Associate Investigator (AI)), Skouteris, H. (Associate Investigator (AI)) & Morris, H. (Associate Investigator (AI))
Department of Health, Disability and Ageing (Australia)
14/04/22 → 7/09/25
Project: Research
-
The MPCCC Precision Medicine Scholarship
Chu, S. (Primary Chief Investigator (PCI)) & Fuller, P. (Chief Investigator (CI))
6/12/21 → 16/12/24
Project: Research
-
Precision Medicine for hypertension: Early detection of primary aldosteronism
Yang, J. (Primary Chief Investigator (PCI)), Fuller, P. (Chief Investigator (CI)), Young, M. (Chief Investigator (CI)), Stowasser, M. (Chief Investigator (CI)), Russell, G. (Chief Investigator (CI)), Bach, L. (Chief Investigator (CI)), Gilfillan, C. (Chief Investigator (CI)), Lu, Z. X. (Chief Investigator (CI)), Reid, C. (Chief Investigator (CI)), Chen, G. (Chief Investigator (CI)) & Gwini, S. (Chief Investigator (CI))
1/07/19 → 30/06/23
Project: Research
-
Primary Aldosteronism: Prevalence, Clinical Features, and Biomarkers
Libianto, R. (Primary Chief Investigator (PCI)) & Fuller, P. (Supervisor)
National Heart Foundation of Australia
18/02/19 → 17/02/22
Project: Research
-
Preferences for subtyping primary aldosteronism: a discrete choice experiment
Woode, M. E., Chong, W., Ng, E., Lu-Shirzad, S., Gwini, S. M., Fuller, P. J., Yang, J. & Chen, G., Mar 2026, In: Journal of the Endocrine Society. 10, 3, 10 p., bvaf185.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile1 Link opens in a new tab Citation (Scopus) -
Adrenal vein sampling: accuracy of earlier sampling post adrenocorticotropic hormone (ACTH) administration
Tee, Q. X., Doery, J. C. G., Desra, A., Fuller, P. J., Yang, J. & Lau, K. K., May 2025, In: Clinical Radiology. 84, 7 p., 106861.Research output: Contribution to journal › Article › Research › peer-review
-
Ascertainment, Awareness and Intersection: PA Meets PTC
Fuller, P. J., Mond, M. & Yang, J., 1 Sept 2025, In: The Journal of Clinical Endocrinology & Metabolism. 110, 9, p. e3169-e3170 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Evaluation of primary aldosteronism testing in hypertensive patients with SLE in a tertiary hospital
Wong, M. (Leading Author), Hoi, A., Kent, J. R., Fuller, P., Yang, J. (Leading Author) & Vincent, F. B. (Leading Author), 18 Feb 2025, In: Lupus Science & Medicine. 12, 1, 3 p., e001524.Research output: Contribution to journal › Letter › Research › peer-review
Open Access -
Mechanisms of ligand-mediated modulation of mineralocorticoid receptor signaling
Fuller, P. J., Yang, J., Young, M. J. & Cole, T. J., 15 Apr 2025, In: Molecular and Cellular Endocrinology. 600, 9 p., 112504.Research output: Contribution to journal › Article › Research › peer-review
4 Link opens in a new tab Citations (Scopus)